GEMYSIS - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
88811294
Word Mark
GEMYSIS
Status
730 - First Extension - Granted
Status Date
2021-08-11
Filing Date
2020-02-26
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-12-22
Attorney Name
Law Office Assigned Location Code
N40
Employee Name
MOLINOFF, JEFFREY S.
Statements
Goods and Services
Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for immunotherapy through genetically engineered cell therapy; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of cancer and tumors for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of immune disorders for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of cancer and tumors for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of immune disorders for medical or clinical purposes; biological and pharmaceutical preparations for the treatment of cancer and immune disorders using genetically engineered cells
Goods and Services
Business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of cancer and tumors; business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of immune disorders; pharmaceutical sales promotion for others
Goods and Services
Pharmaceutical research and development; medical and scientific research and development of cellular immunotherapies for the treatment of cancer and tumors; medical and scientific research and development of cellular immunotherapies for the treatment of immune disorders; conducting clinical trials for others regarding pharmaceutical preparations and drugs in the field of immunotherapy and cell therapy; scientific and technological services, namely, research, analysis, and clinical trials for others in the field of cellular immunotherapy; providing medical and scientific research information in the field of cellular immunotherapies; compiling scientific and or clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of cell therapy, genetics, immunology, rare diseases, and oncology; licensing of technology in the fields of pharmaceuticals and gene therapy
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-03-07
Primary Code
005
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2020-03-07
Primary Code
035
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-03-07
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Thomas Druan
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2020-03-05 | NEW APPLICATION ENTERED IN TRAM |
| 2020-03-07 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-05-15 | ASSIGNED TO EXAMINER |
| 2020-05-15 | NON-FINAL ACTION WRITTEN |
| 2020-05-15 | NON-FINAL ACTION E-MAILED |
| 2020-05-15 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-11-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-11-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-11-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-11-13 | EXAMINERS AMENDMENT -WRITTEN |
| 2020-11-13 | EXAMINERS AMENDMENT E-MAILED |
| 2020-11-13 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2020-11-13 | EXAMINER'S AMENDMENT ENTERED |
| 2020-11-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-12-02 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2020-12-22 | PUBLISHED FOR OPPOSITION |
| 2020-12-22 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-02-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-02-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-02-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-02-16 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2021-06-01 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-06-01 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-06-01 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-08-11 | TEAS EXTENSION RECEIVED |
| 2021-08-11 | EXTENSION 1 FILED |
| 2021-08-11 | EXTENSION 1 GRANTED |
| 2021-08-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
